NCT01366612 Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation Status TERMINATED Phase PHASE3
NCT01362985 Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor Status COMPLETED Phase N/A
NCT01356875 Treatment of Myelodysplastic Syndromes Comparing Hydralazine/Ac. Valproic and Supportive Care in Patients Not Candidates, Refractory and/or Intolerant to Intensive Chemotherapy Status UNKNOWN Phase PHASE2
NCT01347944 MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry Status COMPLETED Phase N/A
NCT01339988 Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT) Status UNKNOWN Phase PHASE4
NCT01338987 Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation Status COMPLETED Phase PHASE2
NCT01336712 Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases Status COMPLETED Phase PHASE2
NCT01333449 Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients Status TERMINATED Phase PHASE2
NCT01331603 Assessment of Labile Plasma Iron (LPI) in Myelodysplastic Syndromes (MDS) and Primary Myelofibrosis Status UNKNOWN Phase N/A
NCT01326845 Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study Status TERMINATED Phase PHASE4
NCT01323920 Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors Status COMPLETED Phase PHASE2
NCT01311258 Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome Status RECRUITING Phase N/A
NCT01305460 Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE1/PHASE2
NCT01300611 TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation Status TERMINATED Phase PHASE1
NCT01295710 Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD) Status COMPLETED Phase PHASE3
NCT01291745 Collection of Biological Data With Potential Prognostic Relevance in Patients With MYELODYSPLASTIC SYNDROMES Status UNKNOWN Phase N/A
NCT01290302 Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza Status COMPLETED Phase PHASE1
NCT01277484 Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML Status UNKNOWN Phase PHASE1
NCT01255319 Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS) Status UNKNOWN Phase N/A